{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:52:39Z","timestamp":1781578359931,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"DOI":"10.1186\/s12955-026-02542-8","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:44:21Z","timestamp":1777463061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world comparative evaluation of quality of life and economic burden in patients with psoriatic arthritis and axial spondyloarthritis under different treatment strategies: a multicenter cross-sectional study"],"prefix":"10.1186","volume":"24","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chichi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"5","key":"2542_CR1","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaad.2024.03.058","volume":"92","author":"LM Perez-Chada","year":"2025","unstructured":"Perez-Chada LM, Elman S, Villa-Ruiz C, Armstrong AW, Gottlieb AB, Merola JF. Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis. J Am Acad Dermatol. 2025;92(5):969\u201382.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2542_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-025-01967-x","volume":"16","author":"Z Xie","year":"2025","unstructured":"Xie Z, Chen Z, Yang Q, Ye Q, Li X, Xie Q, et al. Enhanced diagnosis of axial spondyloarthritis using machine learning with sacroiliac joint MRI: a multicenter study. Insights Imaging. 2025;16(1):91.","journal-title":"Insights Imaging"},{"key":"2542_CR3","doi-asserted-by":"publisher","first-page":"103394","DOI":"10.1016\/j.jaut.2025.103394","volume":"152","author":"S Dang","year":"2025","unstructured":"Dang S, Wither J, Jurisica I, Chandran V, Eder L. Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis. J Autoimmun. 2025;152:103394.","journal-title":"J Autoimmun"},{"issue":"2","key":"2542_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40259-025-00705-5","volume":"39","author":"S Yu","year":"2025","unstructured":"Yu S, Huo AP, Wang YH, Wei JC. Interleukin-23 versus Interleukin-17 Inhibitors in Preventing Incidental Psoriatic Arthritis in Patients with Psoriasis: A Real-World Comparison From the TriNetX US Collaborative Network. BioDrugs. 2025;39(2):297\u2013306.","journal-title":"BioDrugs"},{"key":"2542_CR5","doi-asserted-by":"publisher","first-page":"15013","DOI":"10.1038\/nrdp.2015.13","volume":"1","author":"J Sieper","year":"2015","unstructured":"Sieper J, Braun J, Dougados M, Baeten D. Axial spondyloarthritis. Nat Rev Dis Primers. 2015;1:15013.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"2542_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00296-025-05851-1","volume":"45","author":"P Kuszmiersz","year":"2025","unstructured":"Kuszmiersz P, Gu\u0142a Z, Strach M, Nowakowski J, Biedro\u0144 G, Brkic A, et al. Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort. Rheumatol Int. 2025;45(5):96.","journal-title":"Rheumatol Int"},{"issue":"7","key":"2542_CR7","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s40265-025-02192-y","volume":"85","author":"R Queiro","year":"2025","unstructured":"Queiro R, Pinto-Tasende JA, Montilla-Morales C. Navigating Psoriatic Arthritis: Treatment Pathways and Patient-Specific Strategies for Improved Outcomes. Drugs. 2025;85(7):867\u201382.","journal-title":"Drugs"},{"issue":"4","key":"2542_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/ASW.0000000000000243","volume":"38","author":"RSQ Geng","year":"2025","unstructured":"Geng RSQ, Sibbald RG. Cutaneous Psoriasis: Clinical Aspects and Treatments. Adv Skin Wound Care. 2025;38(4):176\u201382.","journal-title":"Adv Skin Wound Care"},{"issue":"5","key":"2542_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40258-025-00972-x","volume":"23","author":"M Walbaum","year":"2025","unstructured":"Walbaum M, Jana-Valencia N. Aggregate Distributional Cost-Effectiveness Analysis of Biologics for the Treatment of Ankylosing Spondylitis in Chile. Appl Health Econ Health Policy. 2025;23(5):905\u201318.","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"2542_CR10","first-page":"Cd013614","volume":"2","author":"G Cagnotto","year":"2025","unstructured":"Cagnotto G, Bruschettini M, Str\u00f3\u017cyk A, Scir\u00e8 CA, Compagno M. Tumor necrosis factor (TNF) inhibitors for psoriatic arthritis. Cochrane Database Syst Rev. 2025;2(2):Cd013614.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2542_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/apt.70139","volume":"62","author":"S Alsakarneh","year":"2025","unstructured":"Alsakarneh S, Al Ta\u2019ani O, Aburumman R, Mikhail I, Hashash JG, Farraye FA. Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL-17A Inhibitors: A Population-Based Study. Aliment Pharmacol Ther. 2025;62(1):72\u20136.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2542_CR12","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/10600280241288553","volume":"59","author":"ME Greer","year":"2025","unstructured":"Greer ME, Moran SK, Feldman SR. Bimekizumab-bkzx for the Treatment of Plaque Psoriasis: A Drug Review. Ann Pharmacother. 2025;59(6):577\u201384.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"2542_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.clinthera.2025.01.005","volume":"47","author":"SS Zhao","year":"2025","unstructured":"Zhao SS, Riley D, Hernandez G, Alam U. Comparative safety of JAK inhibitors versus TNF or IL-17 inhibitors for cardiovascular disease and cancer in psoriatic arthritis and axial spondyloarthritis. Clin Ther. 2025;47(4):293\u20137.","journal-title":"Clin Ther"},{"issue":"6","key":"2542_CR14","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/rheumatology\/keaf161","volume":"64","author":"MLM Mulder","year":"2025","unstructured":"Mulder MLM, Jones GT, Rotariu O, Helliwell PS. Exploring the relationship between skin severity and PASDAS in psoriatic arthritis: a cross-sectional study in the BSR-PsA and GRACE cohorts. Rheumatology (Oxford). 2025;64(6):3478\u201382.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2542_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s13018-024-05072-5","volume":"19","author":"J Wang","year":"2024","unstructured":"Wang J, Li X, Yang F, Guo P, Ren C, Duan Z, et al. Efficacy and safety of mind-body exercise for patients with axial spondyloarthritis: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19(1):586.","journal-title":"J Orthop Surg Res"},{"issue":"2","key":"2542_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00296-025-05791-w","volume":"45","author":"C Pitzalis","year":"2025","unstructured":"Pitzalis C, Myall N, Dey M, Kouranloo K. Severity of skin disease strongly correlates with quality of life in people with psoriatic arthritis: a systematic review. Rheumatol Int. 2025;45(2):39.","journal-title":"Rheumatol Int"},{"issue":"1","key":"2542_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12955-022-02026-5","volume":"20","author":"Q He","year":"2022","unstructured":"He Q, Luo J, Chen J, Yang J, Yao C, Xu C, et al. The validity and reliability of quality of life questionnaires in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2022;20(1):116.","journal-title":"Health Qual Life Outcomes"},{"key":"2542_CR18","doi-asserted-by":"crossref","unstructured":"Fattorini F, Carli L, Cigolini C, Esti L, Di Battista M, Mosca M, et al. Age at onset impact on clinical profile, treatment, and real-life perception in spondyloarthritis patients, enhancing a personalized approach: a monocentric cohort analysis. J Pers Med. 2026;16(2).","DOI":"10.3390\/jpm16020063"},{"issue":"8","key":"2542_CR19","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1111\/jcmm.14410","volume":"23","author":"M Zhang","year":"2019","unstructured":"Zhang M, Gu Y, Huang S, Lou Q, Xie Q, Xu Z, et al. Copy number variations and polymorphisms in HSP90AB1 and risk of systemic lupus erythematosus and efficacy of glucocorticoids. J Cell Mol Med. 2019;23(8):5340\u20138.","journal-title":"J Cell Mol Med"},{"issue":"8","key":"2542_CR20","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665\u201373.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2542_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"2542_CR22","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s13555-024-01258-1","volume":"14","author":"PJ Mease","year":"2024","unstructured":"Mease PJ, Blauvelt A, Sima AP, Beaty SW, Low R, Gomez B, et al. Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2024;14(10):2805\u201325.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"1","key":"2542_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11845-024-03846-8","volume":"194","author":"EN \u015een","year":"2025","unstructured":"\u015een EN, Sar\u0131ta\u015f F, \u00d6zt\u00fcrk \u00d6. Synchronous and asynchronous remote core stability exercises in patients with axial spondyloarthritis: a randomized-controlled clinical trial. Ir J Med Sci. 2025;194(1):137\u201346.","journal-title":"Ir J Med Sci"},{"issue":"5","key":"2542_CR24","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.2024.20917","volume":"333","author":"M Bittar","year":"2025","unstructured":"Bittar M, Deodhar A. Axial Spondyloarthritis: A Review. JAMA. 2025;333(5):408\u201320.","journal-title":"JAMA"},{"issue":"6","key":"2542_CR25","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s10067-025-07452-6","volume":"44","author":"G Biedro\u0144","year":"2025","unstructured":"Biedro\u0144 G, Wilk M, Nowakowski J, Kuszmiersz P, Gu\u0142a Z, Strach M, et al. Associations between comorbidities and patient-reported outcomes in axial spondyloarthritis: data from a single-center real-world cohort. Clin Rheumatol. 2025;44(6):2311\u201320.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"2542_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/bjd.20765","volume":"186","author":"\u00c1 Szab\u00f3","year":"2022","unstructured":"Szab\u00f3 \u00c1, Brodszky V, Rencz F. A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16. Br J Dermatol. 2022;186(3):485\u201395.","journal-title":"Br J Dermatol"},{"issue":"1","key":"2542_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.62.1.20","volume":"62","author":"LC Doward","year":"2003","unstructured":"Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003;62(1):20\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2542_CR28","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jamadermatol.2022.0364","volume":"158","author":"L Pina Vegas","year":"2022","unstructured":"Pina Vegas L, Penso L, Claudepierre P, Sbidian E. Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database. JAMA Dermatol. 2022;158(5):513\u201322.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"2542_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20090","volume":"20","author":"M Corbett","year":"2016","unstructured":"Corbett M, Soares M, Jhuti G, Rice S, Spackman E, Sideris E, et al. Tumour necrosis factor-\u03b1 inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation. Health Technol Assess. 2016;20(9):1\u2013v334.","journal-title":"Health Technol Assess"},{"issue":"6","key":"2542_CR30","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/ard-2024-225531","volume":"83","author":"L Gossec","year":"2024","unstructured":"Gossec L, Kerschbaumer A, Ferreira RJO, Aletaha D, Baraliakos X, Bertheussen H, et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update. Ann Rheum Dis. 2024;83(6):706\u201319.","journal-title":"Ann Rheum Dis"},{"key":"2542_CR31","doi-asserted-by":"crossref","unstructured":"Marzo-Ortega H, Navarro-Compan V, Dubreuil M, Mease PJ, Magrey M, Rudwaleit M, et al. Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: 2-year results from two phase 3 studies. RMD Open. 2025;11(4).","DOI":"10.1136\/rmdopen-2025-006013"},{"key":"2542_CR32","doi-asserted-by":"crossref","unstructured":"James L, Hailey LH, Suribhatla R, McGagh D, Amarnani R, Bundy CE, et al. The impact of psoriatic arthritis on quality of life: a systematic review. Ther Adv Musculoskelet Dis. 2024;16:1759720X241295920.","DOI":"10.1177\/1759720X241295920"},{"key":"2542_CR33","doi-asserted-by":"crossref","unstructured":"K\u0131l\u0131\u00e7 G, K\u0131l\u0131\u00e7 E, Tekeo\u011flu \u0130, Sarg\u0131n B, Cengiz G, Balta NC, et al. Beyond expectations: disease duration and psychological burden in psoriatic arthritis. Rheumatol Int. 2023;43(9):1695\u2013704.","DOI":"10.1007\/s00296-023-05379-2"},{"key":"2542_CR34","doi-asserted-by":"crossref","unstructured":"Garrido-Cumbrera M, Poddubnyy D, Gossec L, G\u00e1lvez-Ruiz D, Bundy C, Mahapatra R, et al. The European map of axial spondyloarthritis: capturing the patient per spective-an analysis of 2846 patients across 13 countries. Curr Rheumatol Rep. 2019;21(5):19.","DOI":"10.1007\/s11926-019-0819-8"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-026-02542-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-026-02542-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-026-02542-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:22:33Z","timestamp":1781576553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12955-026-02542-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2542"],"URL":"https:\/\/doi.org\/10.1186\/s12955-026-02542-8","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (Approval No. XYFY2024-KL632-01). Written informed consent was obtained from all participants prior to enrollment, in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for both study participation and publication of anonymized data was obtained from all participants before data collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}